JMP Securities analyst Jason Butler maintained a Buy rating on Cytokinetics (CYTK – Research Report) today and set a price target of $78.00.

JMP Securities analyst Reni Benjamin maintained a Buy rating on Blueprint Medicines (BPMC – Research Report) today and set a price target of ...

JMP Securities maintained its Market Perform rating on Apollo Global Management (NYSE:APO) shares without setting a new price ...

JMP Securities maintained a bullish stance on Confluent Inc (NASDAQ:CFLT), reiterating a Market Outperform rating and a ...

Covering some solid dividend stocks for JMP, analyst Aaron Hecht sees a reason to bet on higher value in the coming year. He notes that multiple tailwinds are coming together, and will likely lead ...

Unity Software (NYSE:U – Get Free Report)‘s stock had its “market perform” rating reissued by research analysts at JMP ...

Piper Sandler Companies (NYSE:PIPR – Get Free Report)‘s stock had its “market perform” rating reissued by stock analysts at JMP Securities in a research report issued on Monday,Benzinga reports.

JMP Securities raised the price targets on Cloudflare (NET) and CyberArk Software (CYBR), while highlighting an industry ...

JMP Securities analyst Constantine Davides raised the firm’s price target on Option Care Health (OPCH) to $35 from $30 and ...

Google parent Alphabet Inc. has been downgraded to market perform from market outperform by JMP Securities, with the analyst firm highlighting the potential impact of the company’s antitrust battle.

Fintel reports that on January 21, 2025, JMP Securities initiated coverage of Roku (NasdaqGS:ROKU) with a Market Outperform recommendation. As of December 23, 2024, the average one-year price ...